These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 28364817)

  • 21. Use of thymoglobulin induction therapy in the prevention of acute graft rejection episodes following liver transplantation.
    Tchervenkov J; Flemming C; Guttmann RD; des Gachons G
    Transplant Proc; 1997 Nov; 29(7A):13S-15S. PubMed ID: 9366919
    [No Abstract]   [Full Text] [Related]  

  • 22. Hot-topic debate on hepatitis C virus: the type of immunosuppression matters.
    Trotter JF
    Liver Transpl; 2011 Nov; 17 Suppl 3():S20-3. PubMed ID: 21850693
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunosuppression in pediatric liver and intestinal transplantation: a closer look at the arsenal.
    Al-Hussaini A; Tredger JM; Dhawan A
    J Pediatr Gastroenterol Nutr; 2005 Aug; 41(2):152-65. PubMed ID: 16056093
    [No Abstract]   [Full Text] [Related]  

  • 24. Immunosuppression for liver transplantation.
    Geissler EK; Schlitt HJ
    Gut; 2009 Mar; 58(3):452-63. PubMed ID: 19052024
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunosuppression, cancer, and the long-term outcomes after liver transplantation: can we do better?
    Abraham JM; Thompson JA
    Liver Transpl; 2010 Jul; 16(7):809-11. PubMed ID: 20583078
    [No Abstract]   [Full Text] [Related]  

  • 26. Immunosuppression in liver transplantation: monitoring, dose adjustment, reduction, and withdrawal.
    Wall WJ; Ghent CN
    Liver Transpl Surg; 1995 Sep; 1(5 Suppl 1):3-10. PubMed ID: 9346595
    [No Abstract]   [Full Text] [Related]  

  • 27. Present state of immunosuppressive therapy in liver transplant recipients.
    Wiesner RH; Fung JJ
    Liver Transpl; 2011 Nov; 17 Suppl 3():S1-9. PubMed ID: 21850697
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunosuppression in renal transplantation.
    Bonomini V; Scolari MP; Buscaroli A; Liviano D'Arcangelo G; Stefoni S
    Int J Artif Organs; 1997 Feb; 20(2):73-5. PubMed ID: 9093883
    [No Abstract]   [Full Text] [Related]  

  • 29. [Immunosuppression in organ transplantation. New substances and therapeutic approaches].
    Wonigeit K
    Internist (Berl); 1996 Mar; 37(3):229-39. PubMed ID: 8919940
    [No Abstract]   [Full Text] [Related]  

  • 30. Immunosuppression: towards a logical approach in liver transplantation.
    Perry I; Neuberger J
    Clin Exp Immunol; 2005 Jan; 139(1):2-10. PubMed ID: 15606606
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New aspect of immunosuppressive treatment in liver transplantation. How could you induce tolerance in liver transplantation?
    Beaudreuil S; Samuel D; Rouas-Freiss N; Durrbach A
    Transpl Immunol; 2007 Feb; 17(2):98-107. PubMed ID: 17306740
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is there such a thing as protocol immunosuppression in liver transplantation?
    McCaughan GW; Sze KC; Strasser SI
    Expert Rev Gastroenterol Hepatol; 2015 Jan; 9(1):1-4. PubMed ID: 25164689
    [TBL] [Abstract][Full Text] [Related]  

  • 33. De novo autoimmune hepatitis after liver transplantation: A focus on glutathione S-transferase theta 1.
    Ibáñez-Samaniego L; Salcedo M; Vaquero J; Bañares R
    Liver Transpl; 2017 Jan; 23(1):75-85. PubMed ID: 27712026
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of posttransplant hepatitis C infection.
    Aytaman A; Kaufman M; Terrault NA
    Curr Opin Organ Transplant; 2010 Jun; 15(3):301-9. PubMed ID: 20445452
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclosporine-based immunotherapy for pediatric liver transplantation in Hong Kong.
    Chan KL; Saing H; Fan ST; Wei WI; Ng IO; Tsoi NS
    Transplant Proc; 1996 Jun; 28(3):1302-3. PubMed ID: 8658669
    [No Abstract]   [Full Text] [Related]  

  • 36. Immunosuppression for liver transplantation in HCV-infected patients: mechanism-based principles.
    Eghtesad B; Fung JJ; Demetris AJ; Murase N; Ness R; Bass DC; Gray EA; Shakil O; Flynn B; Marcos A; Starzl TE
    Liver Transpl; 2005 Nov; 11(11):1343-52. PubMed ID: 16237712
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis B recurrence in relation to immunosuppression and acute allograft rejection.
    Platz KP; Mueller AR; Haller GW; Naumann U; Berg T; Fukomoto T; Lemmens HP; Hopf U; Lobeck H; Neuhaus P
    Transplant Proc; 1996 Dec; 28(6):3236-7. PubMed ID: 8962252
    [No Abstract]   [Full Text] [Related]  

  • 38. Assessment of chronic rejection in liver graft recipients receiving immunosuppression with low-dose calcineurin inhibitors.
    Barbier L; Garcia S; Cros J; Borentain P; Botta-Fridlund D; Paradis V; Le Treut YP; Hardwigsen J
    J Hepatol; 2013 Dec; 59(6):1223-30. PubMed ID: 23933266
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunosuppression in liver transplantation.
    Post DJ; Douglas DD; Mulligan DC
    Liver Transpl; 2005 Nov; 11(11):1307-14. PubMed ID: 16237688
    [No Abstract]   [Full Text] [Related]  

  • 40. Long-term follow-up of 23 operational tolerant liver transplant recipients.
    Tryphonopoulos P; Ruiz P; Weppler D; Nishida S; Levi DM; Moon J; Tekin A; Velez M; Neuman DR; Island E; Selvaggi G; Tzakis AG
    Transplantation; 2010 Dec; 90(12):1556-61. PubMed ID: 21085060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.